DR. MUBASHIR HUSSAIN ...

The discovery of a new preclinical compound with strong antifungal activity against multidrug-resistant pathogens is ...

Gillis is a strong advocate for the WCSD SWAS program, which he attended for elementary school, and which he says “catalyzed [his] curiosity for the world.” He also thanks Dr. Samuel Lee, MD, Ph.D., ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

Even though effective tuberculosis treatments exist, they're so hard to access in the developing world that more than one ...

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have ...

Responses to Senator Chuck Schumer’s reversal on the stopgap spending bill. Also: A Trump threat to law firms; the risk of TB ...

The company will publish its Full-Year 2024 financial results on March 26, 2025. On the reporting date, BioVersys will issue a press release at 7:00 AM CET.

A new study from researchers at Boston University found microplastics may play a role in the spread of drug-resistant ...

Cefiderocol exhibited clinical utility among a cohort of immunocompromised adult inpatients with MDR infections.

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline severity of HIV Ibalizumab continues to demonstrate ...

Peptides designed by artificial intelligence restrict both drug-resistant bacteria and rapidly evolving viruses.